Lymphatic Filariasis (Elephantiasis)

Lymphatic Filariasis (Elephantiasis)

Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease transmitted by infected mosquitos. Infection is usually acquired in childhood, but the painful and profoundly disfiguring visible manifestations of the disease occur later in life1.


Nearly 1.4 billion people in 73 countries worldwide are threatened by lymphatic filariasis. Over 120 million people are currently infected, with about 40 million disfigured and incapacitated by the disease.


This disease is most commonly found in Southeast Asia and Africa, as well as in other tropical areas.


According to the World Health Organization, there are three conditions of lymphatic filariasis: asymptomatic, acute, and chronic. Most infections are asymptomatic. While this type of infection has no visible symptoms, it causes damage to the lymphatic system and to the kidneys. The symptoms of acute infections include inflammation of the skin and lymph nodes. Symptoms of chronic lymphatic filariasis include tissue swelling, thickening of the limbs, and fluid accumulation1


Lymphatic filariasis can be treated using various drugs and can be prevented by vector control, such as with the use of an insecticide-treated bed net.

Read more at PermaNet®

Malaria Research

IR Mapper is a tool that helps inform vector control strategies by mapping insecticide resistance in mosquitoes that transmit malaria, Zika, Dengue and other mosquito borne diseases. This helps inform vector control strategies.


Buy LifeStraw®

For consumer purchases, visit LifeStraw® to find a local retailer. For each consumer purchase, one school child in Africa will receive clean water for an entire school year. For large quantities purchased for public health settings, contact us


Contact Us

Connect with us

Subscribe to e-newsletter

facebook 32  twitter 32  linkedin 32  youtube 32 

Our Partners

  • carter
  • malarianomore
  • rollback
  • unitednations
  • worldvision